Stocktoria

NovoCure Ltd NVCR

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2015-10-01

NovoCure Ltd statistics & valuation

Market cap$1.8B
P / S2.7×
P / B5.2×
Net margin-20.8%
Return on equity-40.0%
FCF margin-11.5%
Net debt$101.5M
Enterprise value USD$1.9B
Earnings yield EBIT/EV-8.1%
Return on capital-26.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-159.10% -34.80% -25.60% -2.10% 4.00% -10.90% -17.20% -40.60% -27.90% -20.80% 2016201720182019202020212022202320242025
Gross margin (%)
44.20% 68.60% 67.70% 74.80% 78.50% 78.50% 78.60% 74.80% 77.30% 74.50% 2016201720182019202020212022202320242025
Operating margin (%)
-139.10% -22.20% -13.60% -0.30% 6.10% -8.30% -16.60% -45.70% -28.20% -23.50% 2016201720182019202020212022202320242025
Return on equity (%)
-92.60% -54.30% -56.60% -3.30% 4.20% -14.20% -21.00% -57.10% -46.80% -40.00% 2016201720182019202020212022202320242025
Shares outstanding
87.1M 89.5M 93.3M 99.5M 108.9M 104.0M 105.0M 107.1M 108.5M 112.5M 2016201720182019202020212022202320242025
Net debt ($)
-$3.5M $18.8M $8.6M -$27.9M $195.2M $353.4M $450.2M $328.0M -$66.5M $101.5M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-46.70% -23.20% -18.70% -1.50% 1.90% -5.10% -7.80% -18.10% -13.60% -16.90% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-136.60% -22.90% -3.50% 4.60% 17.00% 11.00% 1.80% -19.70% -11.40% -11.50% 2016201720182019202020212022202320242025
Debt / equity (×)
0.68× 0.86× 1.33× 0.69× 0.90× 1.37× 1.28× 1.57× 0.27× 0.57× 2016201720182019202020212022202320242025
EPS ($)
-$0.69 -$0.07 $0.18 -$0.56 -$0.88 -$1.95 -$1.56 -$1.22 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin74.5%77.3%74.8%78.6%78.5%78.5%74.8%67.7%68.6%44.2%
Operating margin-23.5%-28.2%-45.7%-16.6%-8.3%6.1%-0.3%-13.6%-22.2%-139.1%
Net margin-20.8%-27.9%-40.6%-17.2%-10.9%4.0%-2.1%-25.6%-34.8%-159.1%
FCF margin-11.5%-11.4%-19.7%1.8%11.0%17.0%4.6%-3.5%-22.9%-136.6%
Return on assets-16.9%-13.6%-18.1%-7.8%-5.1%1.9%-1.5%-18.7%-23.2%-46.7%
Return on equity-40.0%-46.8%-57.1%-21.0%-14.2%4.2%-3.3%-56.6%-54.3%-92.6%
Debt / equity0.57×0.27×1.57×1.28×1.37×0.90×0.69×1.33×0.86×0.68×
Current ratio2.901.465.787.007.538.805.104.984.887.10

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.